These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

641 related articles for article (PubMed ID: 26537990)

  • 1. MiR-146a-5p suppresses activation and proliferation of hepatic stellate cells in nonalcoholic fibrosing steatohepatitis through directly targeting Wnt1 and Wnt5a.
    Du J; Niu X; Wang Y; Kong L; Wang R; Zhang Y; Zhao S; Nan Y
    Sci Rep; 2015 Nov; 5():16163. PubMed ID: 26537990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-130a-3p attenuates activation and induces apoptosis of hepatic stellate cells in nonalcoholic fibrosing steatohepatitis by directly targeting TGFBR1 and TGFBR2.
    Wang Y; Du J; Niu X; Fu N; Wang R; Zhang Y; Zhao S; Sun D; Nan Y
    Cell Death Dis; 2017 May; 8(5):e2792. PubMed ID: 28518142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulated microRNA-199a-5p inhibits nuclear receptor corepressor 1 translation in mice with non‑alcoholic steatohepatitis.
    Zhang B; Wang R; Du J; Niu J; Zhang R; Xu S; Niu X; Zhang Q; Nan Y
    Mol Med Rep; 2014 Dec; 10(6):3080-6. PubMed ID: 25269746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteopontin promotes collagen I synthesis in hepatic stellate cells by miRNA-129-5p inhibition.
    Chen Y; Ou Y; Dong J; Yang G; Zeng Z; Liu Y; Liu B; Li W; He X; Lan T
    Exp Cell Res; 2018 Jan; 362(2):343-348. PubMed ID: 29196165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SGLT2 inhibitor empagliflozin downregulates miRNA-34a-5p and targets GREM2 to inactivate hepatic stellate cells and ameliorate non-alcoholic fatty liver disease-associated fibrosis.
    Shen Y; Cheng L; Xu M; Wang W; Wan Z; Xiong H; Guo W; Cai M; Xu F
    Metabolism; 2023 Sep; 146():155657. PubMed ID: 37422021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of miR-188-5p alleviates hepatic fibrosis by significantly reducing the activation and proliferation of HSCs through PTEN/PI3K/AKT pathway.
    Riaz F; Chen Q; Lu K; Osoro EK; Wu L; Feng L; Zhao R; Yang L; Zhou Y; He Y; Zhu L; Du X; Sadiq M; Yang X; Li D
    J Cell Mol Med; 2021 Apr; 25(8):4073-4087. PubMed ID: 33689215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetically-Regulated MicroRNA-9-5p Suppresses the Activation of Hepatic Stellate Cells via TGFBR1 and TGFBR2.
    Yu F; Chen B; Fan X; Li G; Dong P; Zheng J
    Cell Physiol Biochem; 2017; 43(6):2242-2252. PubMed ID: 29073595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-146a-5p attenuates liver fibrosis by suppressing profibrogenic effects of TGFβ1 and lipopolysaccharide.
    Zou Y; Cai Y; Lu D; Zhou Y; Yao Q; Zhang S
    Cell Signal; 2017 Nov; 39():1-8. PubMed ID: 28739486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow-derived macrophage contributes to fibrosing steatohepatitis through activating hepatic stellate cells.
    Han J; Zhang X; Lau JK; Fu K; Lau HC; Xu W; Chu ES; Lan H; Yu J
    J Pathol; 2019 Aug; 248(4):488-500. PubMed ID: 30945293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. mir-101-3p Downregulation Promotes Fibrogenesis by Facilitating Hepatic Stellate Cell Transdifferentiation During Insulin Resistance.
    Meroni M; Longo M; Erconi V; Valenti L; Gatti S; Fracanzani AL; Dongiovanni P
    Nutrients; 2019 Oct; 11(11):. PubMed ID: 31671785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LincRNA-p21 Inhibits the Wnt/β-Catenin Pathway in Activated Hepatic Stellate Cells via Sponging MicroRNA-17-5p.
    Yu F; Guo Y; Chen B; Shi L; Dong P; Zhou M; Zheng J
    Cell Physiol Biochem; 2017; 41(5):1970-1980. PubMed ID: 28391277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-125a-5p Contributes to Hepatic Stellate Cell Activation through Targeting FIH1.
    Li G; Li J; Li C; Qi H; Dong P; Zheng J; Yu F
    Cell Physiol Biochem; 2016; 38(4):1544-52. PubMed ID: 27074047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-146a-5p Attenuates Fibrosis-related Molecules in Irradiated and TGF-beta1-Treated Human Hepatic Stellate Cells by Regulating PTPRA-SRC Signaling.
    Yuan BY; Chen YH; Wu ZF; Zhuang Y; Chen GW; Zhang L; Zhang HG; Cheng JC; Lin Q; Zeng ZC
    Radiat Res; 2019 Dec; 192(6):621-629. PubMed ID: 31560641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exosomes derived from miR-181-5p-modified adipose-derived mesenchymal stem cells prevent liver fibrosis via autophagy activation.
    Qu Y; Zhang Q; Cai X; Li F; Ma Z; Xu M; Lu L
    J Cell Mol Med; 2017 Oct; 21(10):2491-2502. PubMed ID: 28382720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peroxisome proliferator-activated receptors gamma reverses hepatic nutritional fibrosis in mice and suppresses activation of hepatic stellate cells in vitro.
    Yu J; Zhang S; Chu ES; Go MY; Lau RH; Zhao J; Wu CW; Tong L; Zhao J; Poon TC; Sung JJ
    Int J Biochem Cell Biol; 2010 Jun; 42(6):948-57. PubMed ID: 20156580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-146a-5p Negatively Regulates Pro-Inflammatory Cytokine Secretion and Cell Activation in Lipopolysaccharide Stimulated Human Hepatic Stellate Cells through Inhibition of Toll-Like Receptor 4 Signaling Pathways.
    Chen Y; Zeng Z; Shen X; Wu Z; Dong Y; Cheng JC
    Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27399683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin ameliorates activation of hepatic stellate cells and hepatic fibrosis by succinate and GPR91 inhibition.
    Nguyen G; Park SY; Le CT; Park WS; Choi DH; Cho EH
    Biochem Biophys Res Commun; 2018 Jan; 495(4):2649-2656. PubMed ID: 29278707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA NEAT1 promotes hepatic lipid accumulation via regulating miR-146a-5p/ROCK1 in nonalcoholic fatty liver disease.
    Chen X; Tan XR; Li SJ; Zhang XX
    Life Sci; 2019 Oct; 235():116829. PubMed ID: 31484042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-221/222 upregulation indicates the activation of stellate cells and the progression of liver fibrosis.
    Ogawa T; Enomoto M; Fujii H; Sekiya Y; Yoshizato K; Ikeda K; Kawada N
    Gut; 2012 Nov; 61(11):1600-9. PubMed ID: 22267590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-9 limits hepatic fibrosis by suppressing the activation and proliferation of hepatic stellate cells by directly targeting MRP1/ABCC1.
    Sun J; Zhang H; Li L; Yu L; Fu L
    Oncol Rep; 2017 Mar; 37(3):1698-1706. PubMed ID: 28098912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.